1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALIMERA SCIENCES INC.

Alimera Sciences Inc.

XNAS: ALIM

Momentum Trap

Watchlist

Portfolio

Share


Insider Trading disclosures for Alimera Sciences Inc.

The latest disclosure was made by Adam Morgan in Alimera Sciences Inc. where a trade of 800,000 Warrants done was reported to US exchanges on Sept. 16, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Adam Morgan Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 16 Sep 2024 800,000 0 - - Warrants
Adam Morgan Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 16 Sep 2024 50,000 0 - - Stock Option (Right to Buy)
Adam Morgan Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 16 Sep 2024 1,825 0 - - Stock Option (Right to Buy)
Adam Morgan Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 16 Sep 2024 4,178,725 0 (0%) 84% - Common Stock
Adam Morgan Director, Ten Percent Owner Sale or transfer of securities back to the company at price $ 0.00 per share. 16 Sep 2024 9,429,808 0 (0%) 189% - Common Stock
Philip Ashman President of Intl Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.83 per share. 26 Mar 2024 12,103 118,274 (2%) 0% 3.8 46,354 Common Stock
Richard S. Eiswirth President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 14,700 14,700 - - Restricted Stock Units
Philip Ashman President of Intl Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 75,000 75,000 - - Performance-Based Restricted Stock Units
Philip Ashman President of Intl Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 6,800 6,800 - - Restricted Stock Units
Elliot Maltz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 75,000 75,000 - - Restricted Stock Units
Elliot Maltz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 75,000 75,000 - - Performance-Based Restricted Stock Units
Jason Werner Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 1,800 1,800 - - Restricted Stock Units
Philip Ashman President of Intl Operations Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.86 per share. 10 Jan 2024 2,938 130,377 (2%) 0% 3.9 11,344 Common Stock
Elliot Maltz Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 75,000 75,000 - - Employee Stock Option (Right to Buy)
Adam Morgan Director, Ten Percent Owner 15 Aug 2023 8,117 0 - - Series B Convertible Preferred Stock
Adam Morgan Director, Ten Percent Owner 15 Aug 2023 6,000 0 - - Series B Convertible Preferred Stock
Adam Morgan Director, Ten Percent Owner 15 Aug 2023 7,000 0 - - Series B Convertible Preferred Stock
Adam Morgan Director, Ten Percent Owner 15 Aug 2023 4,845,392 6,505,046 (130%) 97% 1.7 8,237,166 Common Stock
Adam Morgan Director, Ten Percent Owner 15 Aug 2023 4,178,725 4,178,725 (84%) 84% 1.7 7,103,833 Common Stock
Adam Morgan Director, Ten Percent Owner 15 Aug 2023 2,924,762 9,429,808 (189%) 58% 2.1 6,142,000 Common Stock
C. Daniel Myers Chairman Emeritus Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2023 6,000 6,000 - - Stock Option (Right to Buy)
Adam Morgan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.70 per share. 17 May 2023 1,401,901 1,659,654 (33%) 28% 1.7 2,383,232 Common Stock
Adam Morgan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 17 May 2023 2,057,143 800,000 - - Warrants
Adam Morgan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 May 2023 8,117 8,117 - - Series B Convertible Preferred Stock
Adam Morgan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 17 May 2023 7,000 7,000 - - Series B Convertible Preferred Stock
Jason Werner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2023 921 921 - - Stock Option (Right to Buy)
Russell L. Skibsted Chief Financial Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2023 58,000 75,500 (1%) 1% 0 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2023 186,000 322,518 (6%) 3% 0 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2023 68,000 108,880 (2%) 1% 0 Common Stock
Philip Ashman Chief Operating Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2023 103,000 133,315 (2%) 2% 0 Common Stock
Michael Kaseta Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2023 1,825 1,825 - - Stock Option (Right to Buy)
Adam Morgan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2023 1,825 1,825 - - Stock Option (Right to Buy)
Roger Sawhney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2023 2,252 2,252 - - Stock Option (Right to Buy)
Philip Ashman Chief Operating Officer & SVP Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.81 per share. 03 Feb 2023 2,889 30,315 (0%) 0% 2.8 8,119 Common Stock
Russell L. Skibsted Chief Financial Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2023 52,500 52,500 - - Employee Stock Option (Right to Buy)
Russell L. Skibsted Chief Financial Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2023 17,500 17,500 (0%) 0% 0 Common Stock
Brian K. Halak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 6,000 6,000 - - Stock Option (Right to Buy)
James R. Largent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 6,000 6,000 - - Stock Option (Right to Buy)
C. Daniel Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 6,000 6,000 - - Stock Option (Right to Buy)
Peter J. Pizzo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 6,000 6,000 - - Stock Option (Right to Buy)
Garheng Kong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 6,000 6,000 - - Stock Option (Right to Buy)
John Snisarenko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 6,000 6,000 - - Stock Option (Right to Buy)
Erin Parsons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 6,000 6,000 - - Stock Option (Right to Buy)
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 4.44 per share. 31 Oct 2022 500 136,518 (2%) 0% 4.4 2,219 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 4.44 per share. 31 Oct 2022 500 40,880 (0%) 0% 4.4 2,219 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 4.44 per share. 31 Oct 2022 372 32,185 (0%) 0% 4.4 1,651 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.76 per share. 29 Apr 2022 500 136,018 (2%) 0% 3.8 1,879 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 3.76 per share. 29 Apr 2022 500 40,380 (0%) 0% 3.8 1,879 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.76 per share. 29 Apr 2022 426 31,813 (0%) 0% 3.8 1,600 Common Stock
Philip Ashman Chief Operating Officer & SVP Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.65 per share. 10 Jan 2022 1,175 33,204 (0%) 0% 4.7 5,464 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 25,000 135,518 (2%) 0% 0 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 75,000 75,000 - - Employee Stock Option (Right to Buy)
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 26,250 26,250 - - Employee Stock Option (Right to Buy)
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 8,750 39,880 (0%) 0% 0 Common Stock
Philip Ashman Chief Operating Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 45,000 45,000 - - Employee Stock Option (Right to Buy)
Philip Ashman Chief Operating Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 15,000 34,379 (0%) 0% 0 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 26,250 26,250 - - Employee Stock Option (Right to Buy)
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 8,750 31,387 (0%) 0% 0 Common Stock
Richard S. Eiswirth Director, President and CEO Purchase of securities on an exchange or from another person at price $ 4.50 per share. 15 Dec 2021 484 110,518 (2%) 0% 4.5 2,177 Common Stock
Richard S. Eiswirth Director, President and CEO Purchase of securities on an exchange or from another person at price $ 4.89 per share. 02 Dec 2021 5,000 105,034 (2%) 0% 4.9 24,428 Common Stock
Erin Parsons Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Nov 2021 3,255 3,255 - - Stock Option (Right to Buy)
Richard S. Eiswirth Director, President and CEO Purchase of securities on an exchange or from another person at price $ 5.50 per share. 04 Nov 2021 1,400 100,034 (2%) 0% 5.5 7,700 Common Stock
Richard S. Eiswirth Director, President and CEO Purchase of securities on an exchange or from another person at price $ 4.41 per share. 04 Nov 2021 10,086 98,634 (1%) 0% 4.4 44,446 Common Stock
Richard S. Eiswirth Director, President and CEO Purchase of securities on an exchange or from another person at price $ 4.45 per share. 03 Nov 2021 28,005 88,548 (1%) 0% 4.5 124,745 Common Stock
David Holland Chief Marketing Officer & SVP Purchase of securities on an exchange or from another person at price $ 4.08 per share. 03 Nov 2021 5,000 31,130 (0%) 0% 4.1 20,392 Common Stock
John Philip Jones Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 4.08 per share. 03 Nov 2021 5,000 24,965 (0%) 0% 4.1 20,399 Common Stock
Brian K. Halak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2021 6,000 6,000 - - Stock Option (Right to Buy)
James R. Largent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2021 6,000 6,000 - - Stock Option (Right to Buy)
James R. Largent Director Purchase of securities on an exchange or from another person at price $ 4.31 per share. 02 Nov 2021 10,000 13,000 (0%) 0% 4.3 43,090 Common Stock
C. Daniel Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2021 6,000 6,000 - - Common Stock
Peter J. Pizzo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2021 6,000 6,000 - - Stock Option (Right to Buy)
Garheng Kong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2021 6,000 6,000 - - Stock Option (Right to Buy)
John Snisarenko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2021 6,000 6,000 - - Stock Option (Right to Buy)
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.76 per share. 29 Oct 2021 500 60,543 (1%) 0% 3.8 1,879 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 3.76 per share. 29 Oct 2021 500 26,130 (0%) 0% 3.8 1,879 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.76 per share. 29 Oct 2021 399 19,965 (0%) 0% 3.8 1,499 Common Stock
Brian K. Halak Director Other type of transaction at price $ 0.00 per share. 17 Sep 2021 215 327 (0%) 0% 0 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.56 per share. 30 Apr 2021 500 60,043 (1%) 0% 3.6 1,781 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 3.56 per share. 30 Apr 2021 500 25,630 (0%) 0% 3.6 1,781 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.56 per share. 30 Apr 2021 421 19,566 (0%) 0% 3.6 1,499 Common Stock
Philip Ashman Chief Operating Officer & SVP Sale of securities on an exchange or to another person at price $ 9.62 per share. 08 Apr 2021 45 19,379 (0%) 0% 9.6 433 Common Stock
John Philip Jones Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.64 per share. 09 Mar 2021 1,164 19,145 (0%) 0% 7.6 8,893 Common Stock
David Holland Chief Operating Officer & SVP Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.41 per share. 08 Mar 2021 1,935 25,130 (0%) 0% 7.4 14,348 Common Stock
Philip Ashman Chief Operating Officer & SVP Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.77 per share. 04 Mar 2021 2,533 19,424 (0%) 0% 7.8 19,681 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 52,500 52,500 - - Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 17,500 59,543 (1%) 0% 0 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 16,875 16,875 - - Employee Stock Option (Right to Buy)
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 5,625 27,065 (0%) 0% 0 Common Stock
Philip Ashman Chief Operating Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 30,000 30,000 - - Employee Stock Option (Right to Buy)
Philip Ashman Chief Operating Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 10,000 21,957 (0%) 0% 0 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 5,625 17,981 (0%) 0% 0 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 16,875 16,875 - - Employee Stock Option (Right to Buy)
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 18,750 18,750 - - Employee Stock Option (Right to Buy)
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2021 6,250 14,929 (0%) 0% 0 Common Stock
Philip Ashman Chief Operating Officer & SVP Purchase of securities on an exchange or from another person at price $ 4.50 per share. 04 Nov 2020 1,316 11,957 (0%) 0% 4.5 5,922 Common Stock
Richard S. Eiswirth Director, President and CEO Purchase of securities on an exchange or from another person at price $ 4.15 per share. 02 Nov 2020 2,500 42,043 (0%) 0% 4.2 10,377 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.56 per share. 30 Oct 2020 500 39,543 (0%) 0% 3.6 1,781 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 3.56 per share. 30 Oct 2020 500 21,440 (0%) 0% 3.6 1,781 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.56 per share. 30 Oct 2020 421 12,356 (0%) 0% 3.6 1,499 Common Stock
C. Daniel Myers Director Sale of securities on an exchange or to another person at price $ 6.73 per share. 20 Aug 2020 5,000 5,578 (0%) 0% 6.7 33,650 Common Stock
Brian K. Halak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 3,333 3,333 - - Stock Option (Right to Buy)
James R. Largent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 3,333 3,333 - - Stock Option (Right to Buy)
Mary T. Szela Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 3,333 3,333 - - Stock Option (Right to Buy)
C. Daniel Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 3,333 3,333 - - Stock Option (Right to Buy)
Peter J. Pizzo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 3,333 3,333 - - Stock Option (Right to Buy)
Garheng Kong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 3,333 3,333 - - Stock Option (Right to Buy)
John Snisarenko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 3,333 3,333 - - Stock Option (Right to Buy)
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 3.61 per share. 30 Apr 2020 167 39,043 (0%) 0% 3.6 603 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 3.61 per share. 30 Apr 2020 167 20,940 (0%) 0% 3.6 603 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.61 per share. 30 Apr 2020 167 11,935 (0%) 0% 3.6 603 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2020 10,884 38,876 (0%) 0% 0 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2020 5,172 20,773 (0%) 0% 0 Common Stock
Philip Ashman Chief Operating Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2020 5,389 10,641 (0%) 0% 0 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2020 3,958 11,768 (0%) 0% 0 Common Stock
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2020 4,683 8,679 (0%) 0% 0 Common Stock
Samer Kaba Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.13 per share. 09 Mar 2020 838 4,834 (0%) 0% 6.1 5,137 Common Stock
Samer Kaba Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.63 per share. 09 Mar 2020 838 3,996 (0%) 0% 5.6 4,717 Common Stock
Richard S. Eiswirth Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.67 per share. 05 Mar 2020 1,958 27,992 (0%) 0% 6.7 13,060 Common Stock
Richard S. Eiswirth Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.37 per share. 05 Mar 2020 1,958 29,950 (0%) 0% 6.4 12,472 Common Stock
David Holland Chief Marketing Officer & SVP Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.14 per share. 03 Mar 2020 1,270 15,601 (0%) 0% 6.1 7,798 Common Stock
David Holland Chief Marketing Officer & SVP Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.85 per share. 03 Mar 2020 1,270 16,871 (0%) 0% 6.9 8,700 Common Stock
Philip Ashman Chief Operating Officer & SVP Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.05 per share. 28 Feb 2020 1,447 6,699 (0%) 0% 7.0 10,201 Common Stock
Philip Ashman Chief Operating Officer & SVP Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.15 per share. 28 Feb 2020 1,447 5,252 (0%) 0% 6.1 8,899 Common Stock
John Philip Jones Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.15 per share. 28 Feb 2020 938 7,810 (0%) 0% 6.2 5,769 Common Stock
John Philip Jones Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.05 per share. 28 Feb 2020 938 8,748 (0%) 0% 7.1 6,613 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 53,500 53,500 - - Employee Stock Option (Right to Buy)
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 14,000 14,000 - - Employee Stock Option (Right to Buy)
Philip Ashman Chief Operating Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 20,000 20,000 - - Employee Stock Option (Right to Buy)
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 19,000 19,000 - - Employee Stock Option (Right to Buy)
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2020 17,500 17,500 - - Employee Stock Option (Right to Buy)
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 7.58 per share. 31 Dec 2019 202 31,908 (0%) 0% 7.6 1,531 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 7.58 per share. 31 Dec 2019 106 18,141 (0%) 0% 7.6 803 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 7.58 per share. 31 Dec 2019 78 9,686 (0%) 0% 7.6 591 Common Stock
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 7.58 per share. 31 Dec 2019 93 5,672 (0%) 0% 7.6 705 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 8.24 per share. 13 Dec 2019 186 31,706 (0%) 0% 8.2 1,533 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 8.24 per share. 13 Dec 2019 98 18,035 (0%) 0% 8.2 808 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 8.24 per share. 13 Dec 2019 72 9,608 (0%) 0% 8.2 593 Common Stock
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 8.24 per share. 13 Dec 2019 86 5,579 (0%) 0% 8.2 709 Common Stock
John Philip Jones Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 9.29 per share. 10 Dec 2019 1,000 9,536 (0%) 0% 9.3 9,294 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 5.66 per share. 29 Nov 2019 271 31,520 (0%) 0% 5.7 1,534 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 5.66 per share. 29 Nov 2019 142 17,937 (0%) 0% 5.7 804 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 5.66 per share. 29 Nov 2019 105 8,536 (0%) 0% 5.7 594 Common Stock
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 5.66 per share. 29 Nov 2019 126 5,493 (0%) 0% 5.7 713 Common Stock
John Snisarenko Director Purchase of securities on an exchange or from another person at price $ 4.95 per share. 21 Nov 2019 10,000 10,000 (0%) 0% 5.0 49,500 Common Stock
James R. Largent Director Purchase of securities on an exchange or from another person at price $ 5.11 per share. 19 Nov 2019 3,000 3,000 (0%) 0% 5.1 15,344 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 4.75 per share. 15 Nov 2019 323 31,249 (0%) 0% 4.7 1,534 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 4.75 per share. 15 Nov 2019 170 17,795 (0%) 0% 4.8 808 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 4.75 per share. 15 Nov 2019 125 8,431 (0%) 0% 4.8 594 Common Stock
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 4.75 per share. 15 Nov 2019 149 5,367 (0%) 0% 4.8 708 Common Stock
Richard S. Eiswirth Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.30 per share. 14 Nov 2019 75,000 438,901 (8%) 0% 0.3 22,418 Common Stock
Richard S. Eiswirth Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.30 per share. 14 Nov 2019 25,000 463,901 (9%) 0% 0.3 7,473 Common Stock
John Philip Jones Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.30 per share. 01 Nov 2019 10,000 124,590 (2%) 0% 0.3 3,008 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.24 per share. 31 Oct 2019 2,500 363,901 (7%) 0% 0.2 602 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.28 per share. 31 Oct 2019 5,419 361,401 (7%) 0% 0.3 1,536 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.24 per share. 31 Oct 2019 2,500 264,379 (5%) 0% 0.2 602 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.28 per share. 31 Oct 2019 2,850 261,879 (5%) 0% 0.3 808 Common Stock
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.28 per share. 31 Oct 2019 2,513 78,277 (1%) 0% 0.3 712 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.40 per share. 15 Oct 2019 3,839 355,982 (7%) 0% 0.4 1,536 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.40 per share. 15 Oct 2019 2,020 259,029 (5%) 0% 0.4 808 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.40 per share. 15 Oct 2019 1,490 109,986 (2%) 0% 0.4 596 Common Stock
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.40 per share. 15 Oct 2019 1,779 75,764 (1%) 0% 0.4 712 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.57 per share. 30 Sep 2019 2,694 352,143 (7%) 0% 0.6 1,536 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.57 per share. 30 Sep 2019 1,417 257,009 (5%) 0% 0.6 808 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.57 per share. 30 Sep 2019 1,046 108,496 (2%) 0% 0.6 596 Common Stock
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.57 per share. 30 Sep 2019 1,249 73,985 (1%) 0% 0.6 712 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.41 per share. 13 Sep 2019 3,745 349,449 (7%) 0% 0.4 1,535 Common Stock
David Holland Chief Marketing Officer & SVP Grant, award, or other acquisition of securities at price $ 0.41 per share. 13 Sep 2019 1,970 255,592 (5%) 0% 0.4 808 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.41 per share. 13 Sep 2019 1,454 107,450 (2%) 0% 0.4 596 Common Stock
Samer Kaba Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.41 per share. 13 Sep 2019 1,736 72,736 (1%) 0% 0.4 712 Common Stock
John Snisarenko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2019 46,150 46,150 - - Stock Option (Right to Buy)
Brian K. Halak Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 50,000 50,000 - - Stock Option (Right to Buy)
James R. Largent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 50,000 50,000 - - Stock Option (Right to Buy)
Mary T. Szela Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 50,000 50,000 - - Stock Option (Right to Buy)
C. Daniel Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 50,000 50,000 - - Stock Option (Right to Buy)
Peter J. Pizzo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 50,000 50,000 - - Stock Option (Right to Buy)
Garheng Kong Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2019 50,000 50,000 - - Stock Option (Right to Buy)
Richard S. Eiswirth President and CEO Grant, award, or other acquisition of securities at price $ 0.82 per share. 30 Apr 2019 2,500 345,704 (6%) 0% 0.8 2,061 Common Stock
C. Daniel Myers Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.98 per share. 04 Feb 2019 21,966 158,676 (3%) 0% 1.0 21,472 Common Stock
C. Daniel Myers Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. 04 Feb 2019 21,966 180,642 (3%) 0% 0.9 20,648 Common Stock
Kenneth Green Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. 31 Jan 2019 10,815 220,919 (4%) 0% 0.9 9,194 Common Stock
Kenneth Green Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. 31 Jan 2019 10,815 210,104 (4%) 0% 0.9 10,099 Common Stock
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2019 500,000 500,000 - - Employee Stock Option (Right to Buy)
Richard S. Eiswirth Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2019 201,100 372,870 (7%) 0% 0 Common Stock
Philip Ashman Chief Operating Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2019 92,300 148,700 (2%) 0% 0 Common Stock
Philip Ashman Chief Operating Officer & SVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2019 200,000 200,000 - - Employee Stock Option (Right to Buy)
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2019 79,400 108,596 (2%) 0% 0 Common Stock
John Philip Jones Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2019 250,000 250,000 - - Employee Stock Option (Right to Buy)
John Philip Jones Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. 22 Jan 2019 1,411 29,196 (0%) 0% 0.8 1,171 Common Stock
John Philip Jones Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. 22 Jan 2019 1,411 30,607 (0%) 0% 0.8 1,167 Common Stock
Brian K. Halak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2018 40,000 40,000 - - Stock Option (Right to Buy)
James R. Largent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2018 40,000 40,000 - - Stock Option (Right to Buy)
Mary T. Szela None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2018 40,000 40,000 - - Employee Stock Option (Right to Buy)
Mark J. Brooks None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2018 40,000 40,000 - - Stock Option (Right to Buy)
Calvin W. Roberts None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2018 40,000 40,000 - - Stock Option (Right to Buy)
Peter J. Pizzo None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2018 40,000 40,000 - - Stock Option (Right to Buy)
Garheng Kong None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2018 40,000 40,000 - - Stock Option (Right to Buy)
Richard S. Eiswirth President and CFO Purchase of securities on an exchange or from another person at price $ 1.05 per share. 07 May 2018 10,000 171,770 (0%) 0% 1.1 10,500 Common Stock
Richard S. Eiswirth President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 300,000 300,000 - - Employee Stock Option (Right to Buy)
Richard S. Eiswirth President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 83,800 161,770 (0%) 0% 0 Common Stock
Kenneth Green SVP & Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 185,000 185,000 - - Employee Stock Option (Right to Buy)
Kenneth Green SVP & Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 61,100 231,734 (0%) 0% 0 Common Stock
David Holland SVP of Sales and Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 140,000 140,000 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 395,000 395,000 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 124,100 199,161 (0%) 0% 0 Common Stock
Philip Ashman SVP, EU Managing Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 150,000 150,000 - - Employee Stock Option (Right to Buy)
Philip Ashman SVP, EU Managing Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 56,400 56,400 (0%) 0% 0 Common Stock
Richard S. Eiswirth President and CFO Sale of securities on an exchange or to another person at price $ 1.18 per share. 18 Jan 2018 6,809 77,970 (0%) 0% 1.2 8,036 Common Stock
Richard S. Eiswirth President and CFO Sale of securities on an exchange or to another person at price $ 1.22 per share. 18 Jan 2018 6,601 84,779 (0%) 0% 1.2 8,027 Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.18 per share. 18 Jan 2018 5,404 170,634 (0%) 0% 1.2 6,378 Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.22 per share. 18 Jan 2018 5,234 176,038 (0%) 0% 1.2 6,365 Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 1.18 per share. 18 Jan 2018 12,750 109,588 (0%) 0% 1.2 15,048 Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 1.22 per share. 18 Jan 2018 12,750 122,338 (0%) 0% 1.2 15,504 Common Stock
C. Daniel Myers Director, CEO Sale of securities on an exchange or to another person at price $ 1.18 per share. 18 Jan 2018 26,450 75,061 (0%) 0% 1.2 31,216 Common Stock
C. Daniel Myers Director, CEO Sale of securities on an exchange or to another person at price $ 1.22 per share. 18 Jan 2018 26,450 101,511 (0%) 0% 1.2 32,163 Common Stock
Philip Ashman SVP, EU Managing Director Sale of securities on an exchange or to another person at price $ 1.18 per share. 18 Jan 2018 12,750 0 (0%) 0% 1.2 15,048 Common Stock
Philip Ashman SVP, EU Managing Director Sale of securities on an exchange or to another person at price $ 1.22 per share. 18 Jan 2018 12,750 12,750 (0%) 0% 1.2 15,504 Common Stock
Richard S. Eiswirth President and CFO Sale of securities on an exchange or to another person at price $ 1.23 per share. 16 Jan 2018 7,239 91,380 (0%) 0% 1.2 8,911 Common Stock
Richard S. Eiswirth President and CFO Sale of securities on an exchange or to another person at price $ 1.24 per share. 16 Jan 2018 7,255 98,619 (0%) 0% 1.2 8,979 Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.23 per share. 16 Jan 2018 5,739 181,272 (0%) 0% 1.2 7,065 Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.24 per share. 16 Jan 2018 5,750 187,011 (0%) 0% 1.2 7,116 Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 1.24 per share. 16 Jan 2018 12,750 147,838 (0%) 0% 1.2 15,779 Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 1.23 per share. 16 Jan 2018 12,750 135,088 (0%) 0% 1.2 15,695 Common Stock
C. Daniel Myers Director, CEO Sale of securities on an exchange or to another person at price $ 1.23 per share. 16 Jan 2018 26,450 127,961 (0%) 0% 1.2 32,560 Common Stock
C. Daniel Myers Director, CEO Sale of securities on an exchange or to another person at price $ 1.24 per share. 16 Jan 2018 26,450 154,411 (0%) 0% 1.2 32,735 Common Stock
Philip Ashman SVP, EU Managing Director Sale of securities on an exchange or to another person at price $ 1.24 per share. 16 Jan 2018 12,750 38,250 (0%) 0% 1.2 15,779 Common Stock
Philip Ashman SVP, EU Managing Director Sale of securities on an exchange or to another person at price $ 1.23 per share. 16 Jan 2018 12,750 25,500 (0%) 0% 1.2 15,695 Common Stock
C. Daniel Myers Director, CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2017 500 197,661 (0%) 0% 0 Common Stock
C. Daniel Myers Director, CEO Grant, award, or other acquisition of securities at price $ 1.05 per share. 31 Dec 2017 2,494 202,608 (0%) 0% 1.0 2,607 Common Stock
C. Daniel Myers Director, CEO Grant, award, or other acquisition of securities at price $ 1.06 per share. 31 Dec 2017 2,453 200,114 (0%) 0% 1.1 2,606 Common Stock
C. Daniel Myers Director, CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2017 500 198,161 (0%) 0% 0 Common Stock
C. Daniel Myers Director, CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2017 500 198,661 (0%) 0% 0 Common Stock
Brian K. Halak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 40,000 40,000 - - Stock Option (Right to Buy)
James R. Largent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 40,000 40,000 - - Stock Option (Right to Buy)
Glen Bradley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 40,000 40,000 - - Stock Option (Right to Buy)
Mark J. Brooks None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 40,000 40,000 - - Stock Option (Right to Buy)
Calvin W. Roberts None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 40,000 40,000 - - Stock Option (Right to Buy)
Peter J. Pizzo None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 40,000 40,000 - - Stock Option (Right to Buy)
Garheng Kong None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2017 40,000 40,000 - - Stock Option (Right to Buy)
C. Daniel Myers Director, CEO Sale of securities on an exchange or to another person at price $ 1.39 per share. 10 Mar 2017 21,172 180,861 (0%) 0% 1.4 29,429 Common Stock
Richard S. Eiswirth President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2017 325,000 325,000 - - Employee Stock Option (Right to Buy)
Richard S. Eiswirth President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2017 70,900 105,874 (0%) 0% 0 Common Stock
Kenneth Green SVP & Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2017 200,000 200,000 - - Employee Stock Option (Right to Buy)
Kenneth Green SVP & Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2017 56,200 192,761 (0%) 0% 0 Common Stock
David Holland SVP of Sales and Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2017 150,000 150,000 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2017 51,000 160,588 (0%) 0% 0 Common Stock
C. Daniel Myers Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2017 425,000 425,000 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2017 105,800 202,033 (0%) 0% 0 Common Stock
Philip Ashman SVP, EU Managing Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2017 51,000 51,000 (0%) 0% 0 Common Stock
Philip Ashman SVP, EU Managing Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2017 150,000 150,000 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2016 1,000 94,233 - - Common Stock
C. Daniel Myers Director, CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2016 1,000 95,233 - - Common Stock
C. Daniel Myers Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2016 2,103 96,336 - - Common Stock
C. Daniel Myers Director, CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2016 1,000 96,233 - - Common Stock
C. Daniel Myers Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2016 2,455 98,791 - - Common Stock
Calvin W. Roberts None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Dec 2016 20,000 75,620 - - Common Stock
Calvin W. Roberts None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Dec 2016 30,000 65,820 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Oct 2016 36,177 136,561 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Oct 2016 8,031 100,384 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Oct 2016 36,177 0 - - Employee Stock Option (Right to Buy)
Kenneth Green SVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Oct 2016 8,031 0 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Oct 2016 55,147 0 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Oct 2016 55,147 145,131 - - Common Stock
C. Daniel Myers Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Oct 2016 48,898 96,233 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Oct 2016 27,971 0 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 11 Oct 2016 24,801 109,588 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Oct 2016 27,971 134,389 - - Common Stock
Richard S. Eiswirth President and CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Sep 2016 51,471 34,974 - - Common Stock
Richard S. Eiswirth President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2016 51,471 86,445 - - Common Stock
Richard S. Eiswirth President and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2016 51,471 0 - - Employee Stock Option (Right to Buy)
Peter J. Pizzo None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2016 20,000 20,000 - - Stock Option (Right to Buy)
James R. Largent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2016 20,000 20,000 - - Stock Option (Right to Buy)
Brian K. Halak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2016 20,000 20,000 - - Stock Option (Right to Buy)
Mark J. Brooks None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2016 20,000 20,000 - - Stock Option (Right to Buy)
Calvin W. Roberts None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2016 20,000 20,000 - - Stock Option (Right to Buy)
Garheng Kong None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2016 20,000 20,000 - - Stock Option (Right to Buy)
Glen Bradley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2016 20,000 20,000 - - Stock Option (Right to Buy)
Kate D. Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Apr 2016 20,703 4,002,718 - - Common Stock
Kate D. Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Apr 2016 3,300 3,999,418 - - Common Stock
Kate D. Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Apr 2016 453,870 4,023,421 - - Common Stock
Kate D. Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Apr 2016 100 4,477,291 - - Common Stock
Kate D. Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 20 Apr 2016 700 3,998,718 - - Common Stock
Richard S. Eiswirth President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2016 275,000 275,000 - - Employee Stock Option (Right to Buy)
Kenneth Green SVP & Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2016 195,000 195,000 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2016 450,000 450,000 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2016 125,000 125,000 - - Employee Stock Option (Right to Buy)
Philip Ashman SVP, EU Managing Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2016 125,000 125,000 - - Employee Stock Option (Right to Buy)
Kenneth Green SVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2015 44,118 0 - - Employee Stock Option (Right to Buy)
Kenneth Green SVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2015 44,118 92,353 - - Common Stock
Richard S. Eiswirth COO and CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Dec 2015 31,260 34,974 - - Common Stock
Richard S. Eiswirth COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2015 31,260 66,234 - - Common Stock
Richard S. Eiswirth COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2015 31,260 15,409 - - Employee Stock Option (Right to Buy)
Richard S. Eiswirth COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2015 15,409 50,383 - - Common Stock
Richard S. Eiswirth COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2015 15,409 0 - - Employee Stock Option (Right to Buy)
Richard S. Eiswirth COO and CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Dec 2015 15,409 34,974 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Dec 2015 40,301 632,894 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Dec 2015 27,530 728,718 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Dec 2015 40,301 4,664,585 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Dec 2015 27,529 4,760,408 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Dec 2015 68,294 4,732,879 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Dec 2015 68,294 701,188 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2015 55,257 539,106 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2015 55,257 4,570,798 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2015 12,883 4,515,541 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2015 53,486 4,624,284 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2015 12,882 483,849 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2015 53,487 592,593 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Nov 2015 36,625 4,502,658 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Nov 2015 36,625 470,967 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 30 Oct 2015 8,271 434,342 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 30 Oct 2015 8,271 4,466,033 - - Common Stock
C. Daniel Myers Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Oct 2015 989 89,984 - - Common Stock
David Holland SVP of Sales and Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Oct 2015 2,500 106,418 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Oct 2015 13,165 4,457,762 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Oct 2015 13,165 426,071 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Oct 2015 16,506 4,444,597 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Oct 2015 16,506 412,906 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Oct 2015 12,090 379,283 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Oct 2015 12,091 4,410,975 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Oct 2015 975 367,193 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Oct 2015 17,117 396,400 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Oct 2015 975 4,398,884 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Oct 2015 17,116 4,428,091 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Oct 2015 64,613 4,267,502 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Oct 2015 80,342 4,397,909 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Oct 2015 64,613 235,811 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Oct 2015 80,342 366,218 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Oct 2015 50,065 4,317,567 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Oct 2015 50,065 285,876 - - Common Stock
Richard S. Eiswirth COO and CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Oct 2015 13,625 34,974 - - Common Stock
Richard S. Eiswirth COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2015 13,625 48,599 - - Common Stock
Richard S. Eiswirth COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2015 13,625 0 - - Employee Stock Option (Right to Buy)
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Oct 2015 69,536 79,841 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Oct 2015 71,540 171,198 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Oct 2015 19,816 4,131,349 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Oct 2015 19,817 99,658 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Oct 2015 69,536 4,111,533 - - Common Stock
Flynn E James Other Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Oct 2015 71,540 4,202,889 - - Common Stock
Calvin W. Roberts None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Sep 2015 6,224 101,845 - - Common Stock
Calvin W. Roberts None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Sep 2015 200 2,350 - - Common Stock
Calvin W. Roberts None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Aug 2015 6,389 6,389 - - Common Stock
Calvin W. Roberts None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Aug 2015 2,150 2,150 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Aug 2015 19,600 48,235 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Aug 2015 400 67,835 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Aug 2015 501 87,030 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Aug 2015 304 87,531 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Aug 2015 18,695 68,335 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Aug 2015 400 87,835 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Aug 2015 100 68,235 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Jul 2015 732 4,477,591 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Jul 2015 200 4,477,391 - - Common Stock
Brian K. Halak None Other type of transaction at price $ 0.00 per share. 16 Jul 2015 1,692 1,692 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Jun 2015 1,024 4,478,323 - - Common Stock
Peter J. Pizzo None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2015 20,000 20,000 - - Stock Option (Right to Buy)
James R. Largent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2015 20,000 20,000 - - Stock Option (Right to Buy)
Brian K. Halak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2015 20,000 20,000 - - Stock Option (Right to Buy)
Mark J. Brooks None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2015 20,000 20,000 - - Stock Option (Right to Buy)
Calvin W. Roberts None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2015 20,000 20,000 - - Stock Option (Right to Buy)
Garheng Kong None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2015 20,000 20,000 - - Stock Option (Right to Buy)
Glen Bradley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2015 20,000 20,000 - - Stock Option (Right to Buy)
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Jun 2015 200 4,479,347 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Jun 2015 5,368 4,479,547 - - Common Stock
Richard S. Eiswirth COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2015 2,500 34,974 - - Common Stock
C. Daniel Myers Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Apr 2015 2,000 88,995 - - Common Stock
C. Daniel Myers Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2015 678 90,995 - - Common Stock
David Holland SVP of Sales and Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2015 1,834 103,918 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 24 Apr 2015 1,438 4,486,591 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 24 Apr 2015 1,676 4,484,915 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Apr 2015 3,600 4,488,791 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Apr 2015 762 4,488,029 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Apr 2015 12,800 4,509,891 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Apr 2015 2,700 4,492,391 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Apr 2015 14,800 4,495,091 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Apr 2015 17,300 4,522,691 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Apr 2015 18,400 4,539,991 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Apr 2015 100 4,558,391 - - Common Stock
C. Daniel Myers Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2015 2,000 90,317 - - Common Stock
Richard S. Eiswirth COO and CFO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Mar 2015 10,000 32,474 - - Common Stock
C. Daniel Myers Director, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 19 Feb 2015 2,000 94,317 - - Common Stock
C. Daniel Myers Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Feb 2015 2,000 92,317 - - Common Stock
Richard S. Eiswirth COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2015 275,000 275,000 - - Employee Stock Option (Right to Buy)
Kenneth Green See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2015 195,000 195,000 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2015 450,000 450,000 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2015 125,000 125,000 - - Employee Stock Option (Right to Buy)
Philip Ashman SVP, EU Managing Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2015 125,000 125,000 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jan 2015 2,000 96,317 - - Common Stock
C. Daniel Myers Director, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 07 Jan 2015 4,500 98,317 - - Common Stock
C. Daniel Myers Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Jan 2015 2,000 102,817 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2015 5,000 27,971 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2015 5,000 107,084 - - Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Jan 2015 5,000 102,084 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2014 14,706 88,235 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2014 14,706 0 - - Employee Stock Option (Right to Buy)
C. Daniel Myers President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Dec 2014 2,000 104,817 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2014 117 32,971 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2014 117 107,084 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2014 4,883 0 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2014 4,883 106,967 - - Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Dec 2014 5,000 102,084 - - Common Stock
C. Daniel Myers Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 Oct 2014 2,000 106,817 - - Common Stock
C. Daniel Myers Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2014 460 108,817 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2014 5,000 107,084 - - Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 Oct 2014 5,000 102,084 - - Common Stock
David Holland SVP of Sales and Marketing Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2014 1,222 102,084 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2014 5,000 4,883 - - Employee Stock Option (Right to Buy)
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Oct 2014 57,918 4,558,491 - - Common Stock
C. Daniel Myers Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Oct 2014 2,000 108,357 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2014 5,000 105,862 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2014 5,000 9,883 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Oct 2014 5,000 100,862 - - Common Stock
Michael F. Powell Ten Percent Owner 11 Sep 2014 2,506,270 2,506,270 - - Common Stock
Michael F. Powell Ten Percent Owner Other type of transaction at price $ 0.00 per share. 11 Sep 2014 40,020 40,020 - - Common Stock
Michael F. Powell Ten Percent Owner Other type of transaction at price $ 0.00 per share. 11 Sep 2014 2,000,000 506,270 - - Common Stock
Michael F. Powell Ten Percent Owner 11 Sep 2014 166,667 83,333 - - Series A Convertible Preferred Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Sep 2014 100 4,616,464 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Sep 2014 55 4,616,409 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Sep 2014 2,661 4,616,564 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Sep 2014 11,300 4,647,425 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Sep 2014 25,600 4,621,825 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Sep 2014 2,600 4,619,225 - - Common Stock
C. Daniel Myers Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Sep 2014 2,000 110,357 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Sep 2014 5,000 105,862 - - Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Sep 2014 5,000 100,862 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Sep 2014 5,000 14,883 - - Employee Stock Option (Right to Buy)
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Aug 2014 3,000 4,663,125 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Aug 2014 4,400 4,658,725 - - Common Stock
David Holland SVP of Sales & Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Jul 2014 5,000 98,362 - - Common Stock
David Holland SVP of Sales & Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2014 5,000 103,362 - - Common Stock
David Holland SVP of Sales & Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2014 5,000 24,883 - - Employee Stock Option (Right to Buy)
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 30 Jun 2014 600 4,666,125 - - Common Stock
Philip R. Tracy Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2014 20,000 20,000 - - Stock Option (Right to Buy)
Peter J. Pizzo None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2014 20,000 20,000 - - Stock Option (Right to Buy)
James R. Largent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2014 20,000 20,000 - - Stock Option (Right to Buy)
Brian K. Halak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2014 20,000 20,000 - - Stock Option (Right to Buy)
Mark J. Brooks None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2014 20,000 20,000 - - Stock Option (Right to Buy)
Calvin W. Roberts None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2014 20,000 20,000 - - Stock Option (Right to Buy)
Garheng Kong None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2014 20,000 20,000 - - Stock Option (Right to Buy)
Glen Bradley None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2014 20,000 20,000 - - Stock Option (Right to Buy)
C. Daniel Myers Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Jun 2014 5,000 111,130 - - Common Stock
David Holland Senior Vice President of Sales Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2014 3,205 29,883 - - Employee Stock Option (Right to Buy)
David Holland Senior Vice President of Sales Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2014 3,205 103,362 - - Common Stock
David Holland Senior Vice President of Sales Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2014 1,795 0 - - Employee Stock Option (Right to Buy)
David Holland Senior Vice President of Sales Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Jun 2014 5,000 98,362 - - Common Stock
David Holland Senior Vice President of Sales Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2014 1,795 100,157 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2014 5,000 103,362 - - Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 May 2014 5,000 98,362 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 May 2014 5,000 1,795 - - Employee Stock Option (Right to Buy)
Richard S. Eiswirth COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2014 2,500 19,974 - - Common Stock
Richard S. Eiswirth COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2014 2,500 22,474 - - Common Stock
Susan Caballa See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2014 1,445 78,877 - - Common Stock
Susan Caballa See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2014 543 79,420 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 23,000 4,739,125 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 9,500 4,684,725 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 22,900 4,788,325 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 10,900 4,707,925 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 13,300 4,725,825 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 17,700 4,667,025 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 7,800 4,762,125 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 300 4,666,725 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 14,500 4,848,594 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 26,400 4,811,225 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 13,700 4,694,225 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 18,400 4,769,925 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 7,000 4,718,825 - - Common Stock
Kate Mitchell Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Apr 2014 10,969 4,837,625 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2014 10,000 6,795 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2014 10,000 108,362 - - Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2014 10,000 98,362 - - Common Stock
C. Daniel Myers Director, President and CEO Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 Mar 2014 22,775 116,130 - - Common Stock
C. Daniel Myers Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2014 22,775 138,905 - - Common Stock
C. Daniel Myers Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2014 22,775 0 - - Employee Stock Option (Right to Buy)
Susan Caballa See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2014 8,931 86,363 - - Common Stock
Susan Caballa See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2014 8,931 0 - - Employee Stock Option (Right to Buy)
Susan Caballa See Remarks Sale of securities on an exchange or to another person at price $ 0.00 per share. 04 Mar 2014 8,931 77,432 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2014 5,000 103,362 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2014 5,000 103,362 - - Common Stock
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2014 5,000 16,795 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2014 5,000 21,795 - - Employee Stock Option (Right to Buy)
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Mar 2014 5,000 98,362 - - Common Stock
David Holland SVP of Sales and Marketing Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Mar 2014 5,000 98,362 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2014 73,529 73,529 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 11 Feb 2014 2,500 0 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2014 73,529 0 - - Employee Stock Option (Right to Buy)
Kenneth Green SVP & Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 11 Feb 2014 7,520 7,520 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 11 Feb 2014 2,500 0 - - Common Stock
Kenneth Green SVP & Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 11 Feb 2014 7,520 2,500 - - Common Stock
Richard S. Eiswirth COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jan 2014 50,000 67,474 - - Common Stock
Richard S. Eiswirth COO and CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Jan 2014 50,000 17,474 - - Common Stock
Richard S. Eiswirth COO and CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jan 2014 50,000 46,669 - - Employee Stock Option (Right to Buy)
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Jan 2014 2,230 34,907 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Jan 2014 92,445 3,795,246 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Jan 2014 1,010 37,137 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Jan 2014 204,315 3,590,931 - - Common Stock
C. Daniel Myers Director, President and CEO Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2013 4,000 116,130 - - Common Stock
Richard S. Eiswirth COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2013 235,000 235,000 - - Employee Stock Option (Right to Buy)
Richard S. Eiswirth COO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2013 105,000 105,000 - - Employee Stock Option (Right to Buy)
Kenneth Green SVP & Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2013 65,000 65,000 - - Employee Stock Option (Right to Buy)
Kenneth Green SVP & Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2013 135,000 135,000 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2013 365,000 365,000 - - Employee Stock Option (Right to Buy)
C. Daniel Myers Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2013 110,000 110,000 - - Employee Stock Option (Right to Buy)
Susan Caballa SVP,Regulatory&Medical Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2013 90,000 90,000 - - Employee Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters